Industry association · Italy · EU Transparency Register 986523914777-31
2
positions filed
in the 326 files tracked
1
legislative file
of 326 tracked
1
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 1205 trade and business associations on this site, they rank #814 by legislative files engaged — a count of participation, not a measure of influence.
0.7
declared lobbying FTE
self-declared
€100K+
declared costs / yr (floor)
4
EP accreditations
as declared to the register
2014
in the register since
Declares membership of
Confindustria (Confederazione Generale dell'Industria Italiana)
IFPMA (International Federation of Pharmaceutical Manufacturers and Associations)
EFPIA (European Federation of Pharmaceutical Industries and Associations)
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).
Register category
Trade and business associations
Registered as
Associazione delle Imprese del farmaco (FARMINDUSTRIA)
Head office
Roma, Italy
EU office
Bruxelles
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Work at Farmindustria? so we know who speaks for it.
Their record over time
Farmindustria filed 2 positions between 11 Jun 2025 and 5 Aug 2026, across 1 of the 326 legislative files tracked here, attaching a full position paper 1 time.
Farmindustria, in line with EFPIA, welcomes the Commission’s proposal to create a favourable environment for the development and growth of the biotech sector and, more generally, of the entire pharmaceutical sector. It is a priority to foster an ecosystem that can adapt to future scientific and technological advancements, strengthening the EU’s competitiveness and sustainability.
Filed in Italian · English published by the European Commission
Farmindustria, in line with EFPIA, welcomes the Commission’s initiative to establish a Biotech Act, which aims to create an environment conducive to the development and growth not only of the biotech sector but, more generally, of the entire pharmaceutical sector. An ecosystem that can adapt to future scientific and technological advances, promoting the EU’s competitiveness and sustainability.
Filed in Italian · English published by the European Commission
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Is this your organization?
Everything on this page comes from Farmindustria’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.